Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 20 Jun 2024 – 20 Aug 2026, limited by Motilal Oswal Quant Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Motilal Oswal Quant Fund | Nifty 500 |
|---|---|---|
| 20 Jun 2024 | ₹100.00 | ₹100.00 |
| 25 Aug 2024 | ₹108.45 | ₹104.99 |
| 30 Oct 2024 | ₹103.99 | ₹101.99 |
| 04 Jan 2025 | ₹104.54 | ₹101.81 |
| 11 Mar 2025 | ₹83.46 | ₹91.02 |
| 16 May 2025 | ₹94.13 | ₹102.54 |
| 21 Jul 2025 | ₹100.12 | ₹104.81 |
| 24 Sep 2025 | ₹97.41 | ₹103.91 |
| 29 Nov 2025 | ₹96.66 | ₹107.30 |
| 03 Feb 2026 | ₹97.93 | ₹105.12 |
| 10 Apr 2026 | ₹95.50 | ₹100.19 |
| 15 Jun 2026 | ₹95.53 | ₹102.63 |
| 20 Aug 2026 | ₹99.49 | ₹105.42 |
| Metric | Motilal Oswal · Regular NAV ₹10.01 Very High risk ★★☆☆☆ 1Y | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| +2.32% | +5.83% | |
| — | +15.63% | |
| — | +13.23% | |
| — | +13.85% | |
| -0.24% | +12.26% | |
| +1.76% | — | |
| — | +15.60% | |
| — | +14.52% | |
| — | +13.74% | |
| Risk | ||
| 18.66% | 15.62% | |
| -0.22 | 0.43 | |
| -0.30 | 0.59 | |
| -26.81% | -23.65% | |
| Nifty 500 | — | |
| — | +3.42% | |
| — | 0.95 | |
| — | 105.9% | |
| — | 93.6% | |
| 1.59% | 2.39% | |
| ₹242.48Cr | ₹1,161Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹500 | — | |
| 247% | 45% | |
| Rakesh Shetty | — | |
| 20 Jun 2024 | — | |
| 51 | — | |
| 22.7% | — | |
| 0.8% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.